Novartis drug Promacta® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)

Novartis drug Promacta® shows long-term disease control for chronic/persistent immune thrombocytopenia (ITP)

Oct 18, 2017
Source URL: https://qa1.novartis.us/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp-0

List of links present in page
  1. https://qa1.novartis.us/news/media-releases/novartis-drug-promacta-shows-long-term-disease-control-chronicpersistent-immune-thrombocytopenia-itp-0